Roivant Sciences Ltd.
ROIV
株式のランク
#965
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
株価
$33.73
最終同期: 2026-07-31
時価総額
$24.37B
変化（1日）
-2.28%
変化（1年）
87.82%
国
GB
取引 Roivant Sciences Ltd. (ROIV)
カテゴリー
Healthcare
Roivant Sciences Ltd.（ROIV）の株価履歴
終値の最高値: $34.87 （2026-07-01）
終値の最安値: $10.07 （2020-12-01）
終値の最安値: $10.07 （2020-12-01）
Roivant Sciences Ltd. の株価履歴（2020 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 23.70% |
| 2025 | 80.37% |
| 2024 | 13.38% |
| 2023 | 50.58% |
| 2022 | -31.41% |
| 2021 | 1.51% |
| 2020 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $757.00 | 7.59% |
CH
|
